Comment on

• Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.

  Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C. Macdougall IC, et al. Kidney Int. 2012 Apr;81(8):727-32. doi: 10.1038/ki.2011.500. Epub 2012 Feb 15. Kidney Int. 2012. PMID: 22336988 Review.
• Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies.

  Comont T, Bournet B, Casadevall N, Chauveau D, Faguer S. Comont T, et al. Kidney Int. 2014 Jul;86(1):210-1. doi: 10.1038/ki.2014.144. Kidney Int. 2014. PMID: 24978384 No abstract available.